Debby W. Tsuang
Molecular Biology · 2010–2023
A researcher in the Science corpus: 9 papers; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 116 citations into it
- Physiology — 73 citations into it
- Cellular and Molecular Neuroscience — 9 citations into it
Whom Debby W. Tsuang trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- M. Spillantini (in Physiology)
- M. Goedert (in Physiology)
- D. Selkoe (in Physiology)
Papers from Debby W. Tsuang's perspective
Ordered by how strongly the researchers Debby W. Tsuang trusts endorse each paper. Same corpus, a different order for every researcher.
- Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. (Proceedings of the National Academy of Sciences of the United States of America)
- Role of genes and environments for explaining Alzheimer disease. (Archives of General Psychiatry)
- The National Alzheimer's Coordinating Center (NACC) Database: The Uniform Data Set (Alzheimer Disease and Associated Disorders)
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease (Nature Genetics)
- Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria. (Lancet Neurology)
- MDS clinical diagnostic criteria for Parkinson's disease (Movement Disorders)
- Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial. (The Lancet)
- A Century of Alzheimer's Disease (Science)
- METAL: fast and efficient meta-analysis of genomewide association scans (Bioinform.)
- Quantifying heterogeneity in a meta‐analysis (Statistics in Medicine)
Their papers
- Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease (2013) — 4,257 citations
- Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease (2011) — 1,887 citations
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) — 2,422 citations
- Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies LRRC4C, LHX5-AS1 and nominates ancestry-specific loci PTPRK, GRB14, and KIAA0825 as novel risk loci for Alzheimer disease: the Alzheimer Disease Genetics Consortium (2023) — 1,168 citations
- Mapping genomic loci implicates genes and synaptic biology in schizophrenia (2022) — 2,226 citations
- Research criteria for the diagnosis of prodromal dementia with Lewy bodies (2020) — 615 citations
- Diagnosis and management of dementia with Lewy bodies (2017) — 2,290 citations
- Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease (2014) — 1,239 citations
- Genetics of Alzheimer Disease (2010) — 716 citations